$8.46
0.74 (+9.59%)
Incyte Corp (INCY)
CAPS Rating:
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.